The finding that tumor-induced IL-6 suppresses PPARalpha-regulated ketogenesis was confirmed mechanistically, in vivo, through both gain- and loss-of-function studies (Figures 3C–3F, 4A–4D, S3D–S3F, and S4A–S4G). Here, IL6 is linked to neoplasm.